OrbusNeich Medical Group Holdings Limited is a prominent company specializing in the design, manufacture, and distribution of innovative medical devices primarily in the cardiovascular sector. The group's core focus is on products such as drug-eluting stents and balloon catheters, which are integral in the treatment of coronary heart diseases. These medical devices play a significant role in interventional cardiology, aimed at improving patient outcomes following angioplasty procedures. OrbusNeich serves a wide array of customers, including hospitals, medical clinics, and healthcare professionals across various regions, contributing to the advancement of medical technologies and healthcare solutions globally. Headquartered in Hong Kong, the company leverages its extensive research and development capabilities to maintain a competitive edge in the medical device industry, ensuring compliance with stringent international standards and regulations. OrbusNeich's activities and innovations significantly impact healthcare markets, enhancing the accessibility and quality of cardiovascular treatments.